Dr Lal PathLabs рдХреЗ Business рдореЗрдВ рдХрд╣рд╛рдВ рд╕реЗ рдЖрдПрдЧреА Growth? рдирдП рдЕрд╡рд╕рд░реЛрдВ рдФрд░ Expansion рдкрд░ рдЦрд╛рд╕ рдЪрд░реНрдЪрд╛ | ETNS
ET Now Swadesh ┬╖ 08 Nov 2026 ┬╖ 4 min
Management interview of Dr. Lal PathLabs Ltd (LALPATHLAB), with 2 key numbers discussed.
- Ved Goyal, Group CFO & CEO, Dr Lal Path Labs
Dr Lal PathLabs is driving growth via patient and sample volumes alongside slight realization gains from advanced tests and geographic mix. Network expansion into tier towns and new labs over the past two years has significantly boosted new patient acquisition. Management noted that although four years have passed since the last price hike, it prefers volume-led growth given single-digit organized market share, reviewing pricing every 1-2 quarters. Its preventive healthcare brand, Swasthfit, contributes 26% of revenue and is growing at ~20%, with management planning new packages to maintain momentum.